We have been informed by Israeli Patent Office that our patent application no 248011, concerning our break-through recombinant DNA biotechnology for the construction of a new generation vaccines, biologics, biosimilars, industrial and environmental processes is being processed. We are awaiting for further decisions.
top of page
bottom of page